Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.
Cancer
; 128(17): 3185-3195, 2022 09 01.
Article
in En
| MEDLINE
| ID: mdl-35737639
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell, Marginal Zone
/
Neoplasms
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Cancer
Year:
2022
Type:
Article
Affiliation country:
France